Shi-Chuen Miaw,1,
,
and
I-Cheng Ho1,2,3*
Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Brigham and Women's Hospital,1 Harvard Medical School,3 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts2
Received 15 September 2004/ Accepted 23 October 2004
ROG, a transcriptional repressor, is a direct target gene of NF-AT and a putative negative regulator of T-cell activation. In addition, overexpression of ROG suppresses the activity of GATA-3, implying a role of ROG in the differentiation and function of Th cells. Despite these observations, the function of ROG has yet to be confirmed by loss-of-function approaches. Here we report that ROG-deficient T cells are hypersensitive to anti-CD3 stimulation and produce more interleukin-2 (IL-2) due to enhanced NF-
B activity. ROG-deficient dendritic cells also produce more IL-12p40, another NF-
B target gene. However, ROG-deficient Th cells are capable of differentiating into Th1 and Th2 cells, and ROG-deficient mice have no defect in mounting appropriate Th immune responses in vivo. Thus, ROG is dispensable for the differentiation and function of Th cells but serves as a mediator of NF-AT-initiated suppression of NF-
B. Its mechanism of action and its expression pattern are distinct from those of other transcription factors negatively regulating the activation of T cells.
B.Y.K. and S.-C.M. contributed equally to this work.
Present address: Graduate Institute of Immunology, National Taiwan University, College of Medicine, Taipei 10010, Taiwan.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|